Latest Headlines

Latest Headlines

China Daily carries lengthy industry-linked op-ed against overuse of stents

China Daily has published a lengthy op-ed article by Dwight Clark, medical director of US-Sino HeartCare, which argues that stent implants are too widely used and often unnecessary in China and elsewhere.

India cardiac stent price caps closer after advisory review

An advisory body to India's health ministry has made a recommendation that favors price caps on cardiac stents based on price lists sent by manufacturers, the Economic Times reports.

Indian stentmakers gaining global foothold--is U.S. market next?

Companies in India's diamond-cutting district in Surat, Gujurat, are applying their knowledge of lasers to create something else: stents.

Stents a medical devices bright spot for 'Make in India'

One area in which the "Make in India" government effort may need to highlight further is the stents used by the nation's hospitals. Nearly half were made at home last year.

FDA clears first stroke stent system to go in via the neck from startup Silk Road

The FDA has cleared the first system to reduce stroke risk that introduces a stent via the neck. The device, the Enroute Transcarotid Neuroprotection System from startup Silk Road, is expected to offer an option for patients whose vasculature is too convoluted to introduce a stent via the femoral artery in the groin.

Lombard Medical's first Q1 reports sales doubled as losses widened

Lombard Medical, the U.K.-based medical device maker, reported global sales of its Aorfix stent were 104% higher in the first quarter compared to the same period last year while its losses widened due to the expansion of its business, the company said in its first earnings report since going public.

IPO emigre Lombard Medical looks to raise $60M in a Nasdaq debut

Stentmaker Lombard Medical has set the range for its pending U.S. IPO, aiming to raise $60 million with the sale of 3.6 million shares priced between $15 and $18.

Abbott has won U.S. approval for the peripheral-artery-disease stent it bought last year

Abbott announced on Friday that its Supera Peripheral Stent System has got the FDA's approval to treat blocked blood vessels in the upper leg caused by peripheral artery disease.

OrbusNeich starts up a U.S.-Japan trial of its dual-therapy stent

OrbusNeich has enrolled its first patient in a two-country proof-of-concept study for its innovative dual-therapy stent.

Boston Scientific will expand the use of a key esophageal stent in Europe

Boston Scientific nabbed a new CE mark that allows one of its esophageal stents to be used to treat narrowing of the esophagus caused by benign scar tissue--another win as the company seeks to restore steady revenue expansion after a years-long slump.